Ontogeny of mu opioid agonist anti-nociception in postnatal rats

Developmental Brain Research

Volumn 105, Issue 2, 1998, Pages 269-276

  Thornton, Suzanne R ^a   Compton, David R ^b   Smith, Forrest L ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Huntingdon Life Sciences New Jersey   (United States)

Author keywords

Analgesia; Anti nociception; Fentanyl; Meperidine; Morphine; Neonatal; Opioid; Rat

Indexed keywords

FENTANYL; MU OPIATE RECEPTOR AGONIST; PETHIDINE;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; BLOOD BRAIN BARRIER; BRAIN DEVELOPMENT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; NOCICEPTIVE STIMULATION; NONHUMAN; ONTOGENY; OXIDATIVE STRESS; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; RAT; RECEPTOR POTENTIAL;

ANALGESICS, OPIOID; ANIMALS; ANIMALS, NEWBORN; BRAIN; BRAIN CHEMISTRY; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FENTANYL; MALE; MEPERIDINE; MORPHINE; PAIN MEASUREMENT; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, MU;

EID: 18844468933     PISSN: 01653806     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-3806(97)00185-5     Document Type: Article

References (49)

1. Anand K.J.S., Hickey P.R. Pain and its effects in the human neonate and fetus. N. Engl. J. Med. 317:1987;1321-1329.
2. Brill J.E. Control of pain. Prog. Pediatr. Crit. Care. 8:1992;203-218.
3. McLaughlin C.R., Hull J.G., Edwards W.H., Cramer C.P., Dewey W.L. Neonatal pain: a comprehensive survey of attitudes and practices. J. Pain Symptom Manage. 8:1993;7-16.
4. Dilworth N.M., MacKellar A. Pain relief for the pediatric surgical patient. J. Pediatr. Surg. 22:1987;264-266.
5. Olkkola K.T., Hamunen K., Maunuksela E.L. Clinical pharmacokinetics and pharmacodynamics of opiate analgesics in infants and children. Clin. Pharmacokinet. 28:1995;385-404.
6. Orsini A.J., Leef K.H., Costarino A., Detorre M.D., Stefano J.L. Routine use of fentanyl infusions for pain and stress reduction in infants with respiratory distress syndrome. J. Pediatr. 129:1996;140-145.
7. Pokela M.-L. Pain relief can reduce hypoxemia in distressed neonates during routine treatment procedures. Pediatrics. 93:1994;379-383.
8. Truog R., Anand K. Management of pain in the postoperative neonate. Clin. Perinatol. 16:1989;61-78.
9. Yaster M., Deshpande J.K. Management of pediatric pain with opioid analgesics. J. Pediatr. 113:1988;421-429.
10. Yeh S.Y., Krebs H.A. Development of narcotic drug metabolizing enzymes in the newborn rat. J. Pharmacol. Exp. Ther. 213:1980;28-32.
11. Helmstetter F.J., Calcagnetti D.J., Cramer C.P., Fanselow M.S. Ethylketocyclazocine and bremazocine in neonatal rats. Pharmacol. Biochem. Behav. 30:1988;817-821.
12. Jackson H.C., Kitchen I. Behavioural effects of selective μ-, κ- and δ-opioid agonists in neonatal rats. Psychopharmacology. 97:1989;404-409.
13. Leslie F.M., Tso S., Hulbert D.E. Differential appearance of opiate receptor subtypes in neonatal rat brain. Life Sci. 31:1982;1393-1396.
14. Spain J.W., Roth B.L., Coscia C.J. Differential ontogeny of multiple opioid receptors (μ, δ and κ). J. Neurosci. 5:1985;584-588.
15. Windh R.T., Kuhn C.M. Increased sensitivity to mu opiate anti-nociception in the neonatal rat despite weaker receptor-guanyl nucleotide binding protein coupling. J. Pharmacol. Exp. Ther. 273:1995;1353-1360.
16. D'Amour F.E., Smith D.L. A method for determining loss of pain sensation. J. Pharmacol. Exp. Ther. 72:1941;74-79.
17. Dewey W.L., Harris L.S., Howes J.F., Nuite J.A. The effect of various neurohormonal modulators on the activity of morphine and the narcotic antagonists in the tail-flick and phenylquinone tests. J. Pharmacol. Exp. Ther. 175:1970;435-442.
18. Harris L.S., Pierson A.K. Some narcotic antagonists in the benzomorphan series. J. Pharmacol. Exp. Ther. 143:1964;141-148.
19. DeLean A., Munson P.J., Rodbard D. Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay and physiological dose response curves. Am. J. Physiol. 235:1978;E97-E102.
20. Patrick G.A., Dewey W.L., Spaulding T.C., Harris L.S. Relationship of brain morphine levels to analgesic activity in acutely treated mice and rats and in pellet-implanted mice. J. Pharm. Exp. Ther. 193:1975;876-883.
21. Johannesson T., Becker B.A. Morphine analgesia in rats at various ages. Acta Pharmacol. Toxicol. 33:1973;429-441.
22. Spratto G.R., Dorio R.E. Effect of age on acute morphine response in the rat. Res. Commun. Chem. Pathol. Pharmacol. 19:1978;23-36.
23. T. Reisine, G. Pasternak. Opioid analgesics and antagonists, in: J.G. Hardman, L.E. Limbird, P.B. Molinoff, R.W. Ruddon, A.G. Gilman (Eds.), Goodman and Gilman's the Pharmacological Basis of Therapeutics, McGraw-Hill, New York, 1996.
24. Auguy-Valette A., Cros J., Gouarderes Ch., Gout R., Pontonnier G. Morphine analgesia and cerebral opiate receptors: a developmental study. Br. J. Pharmacol. 63:1978;303-308.
25. Wahlstrom A., Hammer L., Lundin L.-G., Rane A. Morphine metabolism in mouse brain. NIDA Res. Monogr. Ser. 75:1986;603-606.
26. Wahlstrom A., Windblad B., Bixo M., Rane A. Human brain metabolism of morphine and naloxone. Pain. 35:1988;121-127.
27. Borlakoglu J.T., Scott A., Henderson C.J., Wolf C.R. Expression of P450 isoenzymes during rat liver organogenesis. Int. J. Biochem. 25:1993;1659-1668.
28. Cresteil T., Beaune P., Celier C., Leroux J.P., Guengerich F.P. Cytochrome P450 isoenzyme content and monooxygenase activities in rat liver: effect of ontogenesis and pretreatment by phenobarbital and 3-methylcholanthrene. J. Pharmacol. Exp. Ther. 236:1986;269-276.
29. Jayyosi Z., Cooper K.O., Thomas P.E. Brain cytochrome P450 and testosterone metabolism by rat brain subcellular fractions: presence of cytochrome P450 3A immunoreactive protein in rat brain mitochondria. Arch Biochem. Biophys. 298:1992;265-270.
30. Gilbert P.E., Martin W.R. Antagonism of the convulsant effects of heroin, d-propoxyphene, meperidine, normeperidine and thebaine by naloxone in mice. J. Pharmacol. Exp. Ther. 192:1975;538-541.
31. Kaiko R.F., Foley K.M., Grabinski P.Y., Heidrich G., Rogers A.G., Inturrisi C.E., Reidenberg M.M. Central nervous system excitatory effects of meperidine in cancer patients. Ann. Neurol. 13:1983;180-185.
32. Borcus L.O., Skoldefors E., Ehrnebo M. Appearance of pethidine and norpethidine in cerebrospinal fluid of man following intramuscular injection of pethidine. Acta Anaesthesiol. Scand. 27:1983;222-225.
33. Clendinnin J., Petraitis M., Simon E.J. Ontological development of opiate receptors in rodent brain. Brain Res. 118:1976;157-160.
34. 3H]naloxone binding in rat brain. Neuropharmacology. 15:1976;555-560.
35. Kornblum H.I., Hurlbut D.E., Leslie F.M. Postnatal development of multiple opioid receptors in rat brain. Brain Res. 465:1987;21-41.
36. Wohltmann M., Roth B.L., Coscia C.J. Differential postnatal development of μ and κ opiate receptors. Dev. Brain Res. 3:1982;679-684.
37. Milligan G., Streaty R.A., Gierschik P., Spiegel A.M., Klee W.A. Development of opiate receptors and GTP-binding regulatory proteins in neonatal rat brain. J. Biol. Chem. 262:1987;8626-8630.
38. Scuzs M., Coscia C.J. Evidence for δ opiate binding and GTP regulatory proteins in 5-day old rat brain membranes. J. Neurochem. 54:1990;1419-1425.
39. Szucs M., Coscia C.J. Differential coupling of opioid binding sites to guanosine triphosphate binding regulatory proteins in subcellular fractions of rat brains. J. Neurosci. Res. 31:1992;565-572.
40. Bem W.T., Yeung S.J., Belcheva M., Barg J., Coscia C.J. Age-dependent changes in the subcellular distribution of rat brain mu opioid receptors and GTP binding regulatory proteins. J. Neurochem. 57:1991;1470-1477.
41. T. Kenakin, Pharmacological Analysis of Drug-receptor Interaction, 2nd edn., Raven Press, New York, 1993.
42. France C.P., Woods J.H. Discriminative stimulus effects of opioid agonists in morphine-dependent pigeons. J. Pharmacol. Exp. Ther. 254:1990;626-632.
43. Magnan J., Paterson S.J., Tavani A., Kosterlitz H.W. The binding spectrum of narcotic analgesic drugs with different agonist and antagonist properties. Naunyn-Schmiedeberg's Arch Pharmacol. 319:1982;197-205.
44. Miller L., Shaw J.S., Whiting E.M. The contribution of intrinsic activity to the action of opioids in vitro. Br. J. Pharmacol. 87:1986;595-601.
45. Clark R.F., Wei E.M., Anderson P.O. Meperidine: therapeutic use and toxicity. J. Emerg. Med. 13:1995;797-802.
46. Ilkhanipour K., Juels C.R., Langdorf M.I. Pediatric pain control and conscious sedation: a survey of emergency medicine residencies. Acad. Emerg. Med. 1:1994;368-372.
47. P.G. Seitner, B.C. Martin. Survey of analgesic drug prescribing patterns, Washington, DC, The Drug Abuse Council, 1975.
48. Wilson J.E., Pendleton J.M. Oligoanalgesia in the emergency department. Am. J. Emerg. Med. 7:1989;620-623.
49. Woolard D.J., Terndrup T.E. Sedative-analgesic agent administration in children: analysis of use and complications in the emergency department. J. Emerg. Med. 12:1994;453-461.